trending Market Intelligence /marketintelligence/en/news-insights/trending/g3zhipib57ztsxclbpschw2 content esgSubNav
In This List

Bruker CFO departs

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bruker CFO departs

Billerica, Mass.-based healthcare equipment manufacturer Bruker Corp. said Anthony Mattacchione resigned as its CFO.

Mattacchione, who is also a senior vice president of the company, will leave Bruker March 16. Starting April, he will become the CFO of Albany Molecular Research Inc., a contract development and manufacturing organization.

Bruker said it expects to appoint an interim CFO within weeks and will look for a successor for Mattacchione.